Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

MSF Medical Doctor, Mayard Mitial, consults with a patient in St Yves, Delmas 5 displaced persons camp in Port au Prince, Haiti, where around 1,100 people live. Photograph by Pierre Fromentin
Press release
Press release |
22 February 2022
COVID-19

Landmark ‘TRIPS Waiver’ must be agreed now: no time to lose

5 min
MSF health promoter Gareth Botha offers COVID-19 vaccination support to a patient queuing for routine services in Khayelitsha’s Nolungile Clinic. Photograph by MSF
Press release
Press release |
18 February 2022
COVID-19
Africa

MSF responds to WHO announcement that 6 countries will receive tech from mRNA COVID-19 hub

4 min
Field hospital at Ngwelezana Tertiary Hospital in northern KwaZulu-Natal in March 2021.
Press release
Press release |
09 February 2022
COVID-19
South Africa

South Africa must urgently revoke patents on key COVID-19 treatments and vaccines

6 min
"" Photograph by Nikhil Roshan
Press release
Press release |
14 January 2022
COVID-19

MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib

3 min
MSF Medical Doctor, Mayard Mitial (R), and MSF Medical Doctor, Fenelon Jean (L), consult with a patient in St Yves. Photograph by Pierre Fromentin
Press release
Press release |
23 December 2021
COVID-19

MSF responds to FDA approval of COVID-19 drug molnupiravir

3 min
Treating COVID-19 second wave in South Africa Photograph by Chris Allan
Press release
Press release |
22 December 2021
COVID-19

MSF responds to FDA approval of COVID-19 treatment nirmatrelvir/ritonavir

5 min
"" Photograph by MSF
Press release
Press release |
10 December 2021
COVID-19

"Every day, we witness the failure of global solidarity"

3 min
On November 10, MSF held a demonstration in front of the White House in Washington, DC, calling on the Biden administration—which gave pharmaceutical corporations billions of US  taxpayer dollars to develop COVID-19 vaccines—to do more to ensure global vaccine equity. Photograph by Christopher Lee
Press release
Press release |
07 December 2021
COVID-19

One year after the first shot, pharma must urgently “share the tech” of COVID-19 vaccines

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury